Examples of new drug formulations include liposomal doxorubicin, which enhances the delivery of the anticancer drug doxorubicin, and insulin-loaded biodegradable polymers that offer sustained release for diabetes management. These formulations exemplify how innovative delivery systems can improve therapeutic outcomes and reduce toxicity.
